H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
Europe - FRA:2HRA - DE000A2E4T77 - Common Stock
4.95 EUR
+0.03 (+0.61%)
Taking everything into account, 2HRA scores 4 out of 10 in our fundamental rating. 2HRA was compared to 67 industry peers in the Chemicals industry. 2HRA has an average financial health and profitability rating. 2HRA has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
2HRA had positive earnings in the past year.
In the past year 2HRA had a positive cash flow from operations.
Of the past 5 years 2HRA 4 years were profitable.
2HRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.84%, 2HRA perfoms like the industry average, outperforming 49.25% of the companies in the same industry.
2HRA has a Return On Equity (1.97%) which is in line with its industry peers.
2HRA has a Return On Invested Capital (2.70%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for 2HRA is below the industry average of 7.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.84% | ||
| ROE | 1.97% | ||
| ROIC | 2.7% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
1.3 Margins
Looking at the Profit Margin, with a value of 0.62%, 2HRA is in line with its industry, outperforming 47.76% of the companies in the same industry.
2HRA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.39%, 2HRA is in line with its industry, outperforming 41.79% of the companies in the same industry.
In the last couple of years the Operating Margin of 2HRA has grown nicely.
2HRA has a Gross Margin of 24.30%. This is in the lower half of the industry: 2HRA underperforms 64.18% of its industry peers.
2HRA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.39% | ||
| PM (TTM) | 0.62% | ||
| GM | 24.3% |
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 2HRA is destroying value.
Compared to 1 year ago, 2HRA has about the same amount of shares outstanding.
The number of shares outstanding for 2HRA remains at a similar level compared to 5 years ago.
2HRA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.21 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
2HRA's Altman-Z score of 2.21 is in line compared to the rest of the industry. 2HRA outperforms 47.76% of its industry peers.
2HRA has a debt to FCF ratio of 4.23. This is a neutral value as 2HRA would need 4.23 years to pay back of all of its debts.
2HRA's Debt to FCF ratio of 4.23 is amongst the best of the industry. 2HRA outperforms 86.57% of its industry peers.
2HRA has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
2HRA has a better Debt to Equity ratio (0.14) than 77.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.23 | ||
| Altman-Z | 2.21 |
ROIC/WACC0.49
WACC5.57%
2.3 Liquidity
2HRA has a Current Ratio of 1.48. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.48, 2HRA is doing worse than 62.69% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that 2HRA may have some problems paying its short term obligations.
2HRA's Quick ratio of 0.81 is on the low side compared to the rest of the industry. 2HRA is outperformed by 70.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
2HRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.00%.
The earnings per share for 2HRA have been decreasing by -40.40% on average. This is quite bad
Looking at the last year, 2HRA shows a decrease in Revenue. The Revenue has decreased by -0.94% in the last year.
2HRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)-17%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-226.15%
Revenue 1Y (TTM)-0.94%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-9.25%
3.2 Future
2HRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.54% yearly.
The Revenue is expected to grow by 0.12% on average over the next years.
EPS Next Y-36.17%
EPS Next 2Y-7.75%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue Next Year-4.54%
Revenue Next 2Y-1.03%
Revenue Next 3Y0.12%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.57, the valuation of 2HRA can be described as rather expensive.
2HRA's Price/Earnings ratio is in line with the industry average.
2HRA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.26, which indicates a rather expensive current valuation of 2HRA.
2HRA's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.43. 2HRA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.57 | ||
| Fwd PE | 24.26 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 2HRA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than 2HRA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.95 | ||
| EV/EBITDA | 2.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.75%
EPS Next 3Y2.54%
5. Dividend
5.1 Amount
2HRA has a Yearly Dividend Yield of 2.02%.
2HRA's Dividend Yield is comparable with the industry average which is at 3.26.
Compared to an average S&P500 Dividend Yield of 2.36, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
2HRA pays out 45.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.84%
EPS Next 2Y-7.75%
EPS Next 3Y2.54%
FRA:2HRA (11/12/2025, 7:00:00 PM)
4.95
+0.03 (+0.61%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners2.43%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap184.24M
Revenue(TTM)1.32B
Net Income(TTM)8.12M
Analysts40
Price Target5.1 (3.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP45.84%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.26%
EPS NY rev (3m)-52.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)-6.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.57 | ||
| Fwd PE | 24.26 | ||
| P/S | 0.14 | ||
| P/FCF | 4.95 | ||
| P/OCF | 2.06 | ||
| P/B | 0.45 | ||
| P/tB | 0.48 | ||
| EV/EBITDA | 2.74 |
EPS(TTM)0.21
EY4.24%
EPS(NY)0.2
Fwd EY4.12%
FCF(TTM)1
FCFY20.19%
OCF(TTM)2.4
OCFY48.5%
SpS35.35
BVpS11.05
TBVpS10.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.84% | ||
| ROE | 1.97% | ||
| ROCE | 4.57% | ||
| ROIC | 2.7% | ||
| ROICexc | 3.02% | ||
| ROICexgc | 3.18% | ||
| OM | 2.39% | ||
| PM (TTM) | 0.62% | ||
| GM | 24.3% | ||
| FCFM | 2.83% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexgc growth 3Y-25.59%
ROICexgc growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score7
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.23 | ||
| Debt/EBITDA | 0.59 | ||
| Cap/Depr | 83.14% | ||
| Cap/Sales | 3.96% | ||
| Interest Coverage | 3.77 | ||
| Cash Conversion | 94.9% | ||
| Profit Quality | 458.04% | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 2.21 |
F-Score7
WACC5.57%
ROIC/WACC0.49
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%-226.15%
EPS Next Y-36.17%
EPS Next 2Y-7.75%
EPS Next 3Y2.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.94%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%-9.25%
Revenue Next Year-4.54%
Revenue Next 2Y-1.03%
Revenue Next 3Y0.12%
Revenue Next 5YN/A
EBIT growth 1Y0.91%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year177.8%
EBIT Next 3Y45.55%
EBIT Next 5YN/A
FCF growth 1Y79.14%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-7%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%
H&R GMBH & CO KGAA / 2HRA.DE FAQ
Can you provide the ChartMill fundamental rating for H&R GMBH & CO KGAA?
ChartMill assigns a fundamental rating of 4 / 10 to 2HRA.DE.
Can you provide the valuation status for H&R GMBH & CO KGAA?
ChartMill assigns a valuation rating of 4 / 10 to H&R GMBH & CO KGAA (2HRA.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for H&R GMBH & CO KGAA?
H&R GMBH & CO KGAA (2HRA.DE) has a profitability rating of 4 / 10.
How financially healthy is H&R GMBH & CO KGAA?
The financial health rating of H&R GMBH & CO KGAA (2HRA.DE) is 5 / 10.
What is the expected EPS growth for H&R GMBH & CO KGAA (2HRA.DE) stock?
The Earnings per Share (EPS) of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -36.17% in the next year.